{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T03:29:18Z","timestamp":1788838158056,"version":"build-2803163510"},"reference-count":101,"publisher":"MDPI AG","issue":"4","license":[{"start":{"date-parts":[[2021,4,7]],"date-time":"2021-04-07T00:00:00Z","timestamp":1617753600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","award":["Ricerca Corrente"],"award-info":[{"award-number":["Ricerca Corrente"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]},{"name":"AlzChem Trostberg GmbH (Trostberg, Germany)","award":["It paid article processing charges"],"award-info":[{"award-number":["It paid article processing charges"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nutrients"],"abstract":"<jats:p>Creatine is a key player in heart contraction and energy metabolism. Creatine supplementation (throughout the paper, only supplementation with creatine monohydrate will be reviewed, as this is by far the most used and best-known way of supplementing creatine) increases creatine content even in the normal heart, and it is generally safe. In heart failure, creatine and phosphocreatine decrease because of decreased expression of the creatine transporter, and because phosphocreatine degrades to prevent adenosine triphosphate (ATP) exhaustion. This causes decreased contractility reserve of the myocardium and correlates with left ventricular ejection fraction, and it is a predictor of mortality. Thus, there is a strong rationale to supplement with creatine the failing heart. Pending additional trials, creatine supplementation in heart failure may be useful given data showing its effectiveness (1) against specific parameters of heart failure, and (2) against the decrease in muscle strength and endurance of heart failure patients. In heart ischemia, the majority of trials used phosphocreatine, whose mechanism of action is mostly unrelated to changes in the ergogenic creatine-phosphocreatine system. Nevertheless, preliminary data with creatine supplementation are encouraging, and warrant additional studies. Prevention of cardiac toxicity of the chemotherapy compounds anthracyclines is a novel field where creatine supplementation may also be useful. Creatine effectiveness in this case may be because anthracyclines reduce expression of the creatine transporter, and because of the pleiotropic antioxidant properties of creatine. Moreover, creatine may also reduce concomitant muscle damage by anthracyclines.<\/jats:p>","DOI":"10.3390\/nu13041215","type":"journal-article","created":{"date-parts":[[2021,4,7]],"date-time":"2021-04-07T11:31:59Z","timestamp":1617795119000},"page":"1215","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":80,"title":["Role of Creatine in the Heart: Health and Disease"],"prefix":"10.3390","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5971-2200","authenticated-orcid":false,"given":"Maurizio","family":"Balestrino","sequence":"first","affiliation":[{"name":"Dipartimento di Neuroscienze, Riabilitazione, Oftalmologia, Genetica e Scienze Materno-Infantili (DINOGMI), University of Genoa, Largo Daneo 3, 16132 Genova, Italy"},{"name":"IRCCS Ospedale Policlinico San Martino, Largo Rosanna Benzi 10, 16132 Genova, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,4,7]]},"reference":[{"key":"ref_1","first-page":"583","article-title":"The hypodynamic state of the frog heart. Further evidence for a phosphocreatine\u2014Creatine pathway","volume":"76","author":"Vassort","year":"1980","journal-title":"J. Physiol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1007\/s00726-011-0877-3","article-title":"The Creatine kinase system and pleiotropic Effects of creatine","volume":"40","author":"Wallimann","year":"2011","journal-title":"Amino Acids"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1007\/s00726-011-0856-8","article-title":"The Creatine Kinase Reaction: A Simple reaction with functional complexity","volume":"40","author":"Sahlin","year":"2011","journal-title":"Amino Acids"},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Balestrino, M., and Adriano, E. (2019). Beyond sports: Efficacy and Safety of creatine supplementation in pathological or paraphysiological conditions of brain and muscle. Med. Res. Rev., 39.","DOI":"10.1002\/med.21590"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1007\/s00726-016-2173-8","article-title":"Potential of Creatine or phosphocreatine supplementation in cerebrovascular disease and in ischemic heart disease","volume":"48","author":"Balestrino","year":"2016","journal-title":"Amino Acids"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1152\/physrev.2000.80.3.1107","article-title":"Creatine and creatinine metabolism","volume":"80","author":"Wyss","year":"2000","journal-title":"Physiol. Rev."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"607S","DOI":"10.1093\/ajcn\/72.2.607S","article-title":"Does Dietary Creatine Supplementation Play a Role in Skeletal Muscle Metabolism and Performance?","volume":"72","author":"Casey","year":"2000","journal-title":"Am. J. Clin. Nutr."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1007\/s00726-016-2189-0","article-title":"Creatine synthesis and exchanges between brain cells: What can be learned from human creatine deficiencies and various experimental models?","volume":"48","author":"Braissant","year":"2016","journal-title":"Amino Acids"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.3181\/00379727-128-33212","article-title":"Creatine synthesis in the testis","volume":"128","author":"Koszalka","year":"1968","journal-title":"Proc. Soc. Exp. Biol. Med."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1095\/biolreprod58.6.1437","article-title":"Creatine synthesis and transport systems in the male rat reproductive tract","volume":"58","author":"Lee","year":"1998","journal-title":"Biol. Reprod."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1093\/cvr\/cvs272","article-title":"Moderate elevation of intracellular creatine by targeting the creatine transporter protects mice from acute myocardial infarction","volume":"96","author":"Lygate","year":"2012","journal-title":"Cardiovasc. Res."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"19","DOI":"10.2174\/1389557515666150722102151","article-title":"Augmentation of creatine in the heart","volume":"16","author":"Zervou","year":"2016","journal-title":"Mini Rev. Med. Chem."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"I16","DOI":"10.1161\/CIRCULATIONAHA.105.000448","article-title":"Myocardial Expression of the arginine: Glycine Amidinotransferase gene is elevated in heart failure and normalized after recovery: Potential implications for local Creatine synthesis","volume":"114","author":"Cullen","year":"2006","journal-title":"Circulation"},{"key":"ref_14","first-page":"1284","article-title":"Degradation and synthesis of creatine in isolated toad heart","volume":"240","author":"Nekhorocheff","year":"1955","journal-title":"C. R. Hebd. S\u00e9ance Acad. Sci."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1042\/bj0311136","article-title":"The Metabolism of creatine: The conversion of arginine into creatine in the isolated rabbit heart","volume":"31","author":"Fisher","year":"1937","journal-title":"Biochem. J."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1023\/A:1011908606819","article-title":"Creatine and the creatine transporter: A review","volume":"224","author":"Snow","year":"2001","journal-title":"Mol. Cell Biochem."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/s12640-019-00053-7","article-title":"Creatine as a Neuroprotector: An Actor that Can Play Many Parts","volume":"423","author":"Marques","year":"2019","journal-title":"Neurotox Res."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1007\/s11906-006-0023-x","article-title":"On the hypothesis that the failing heart is energy starved: Lessons learned from the metabolism of ATP and creatine","volume":"8","author":"Ingwall","year":"2006","journal-title":"Curr. Hypertens. Rep."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1007\/s00726-016-2188-1","article-title":"The role of dietary creatine","volume":"48","author":"Brosnan","year":"2016","journal-title":"Amino Acids"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1042\/cs0830367","article-title":"Elevation of creatine in resting and exercised muscle of normal subjects by Creatine supplementation","volume":"83","author":"Harris","year":"1992","journal-title":"Clin. Sci."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1016\/S0024-3205(01)01268-1","article-title":"Changes of tissue creatine concentrations upon oral supplementation of Creatine-monohydrate in various animal species","volume":"69","author":"Ipsiroglu","year":"2001","journal-title":"Life Sci."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"R698","DOI":"10.1152\/ajpregu.1999.277.3.R698","article-title":"Increase of total creatine in human brain after oral supplementation of Creatine-monohydrate","volume":"277","author":"Dechent","year":"1999","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1249\/00005768-199401000-00007","article-title":"The Importance of the Creatine Kinase Reaction: The Concept of Metabolic Capacitance","volume":"26","author":"Sweeney","year":"1994","journal-title":"Med. Sci. Sports Exerc."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1123\/ijsnem.2017-0343","article-title":"Evidence-based supplements for the enhancement of athletic performance","volume":"28","author":"Peeling","year":"2018","journal-title":"Int. J. Sport Nutr. Exerc. Metab."},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Kreider, R.B., Kalman, D.S., Antonio, J., Ziegenfuss, T.N., Wildman, R., Collins, R., Candow, D.G., Kleiner, S.M., Almada, A.L., and Lopez, H.L. (2017). International Society of Sports Nutrition Position Stand: Safety and efficacy of creatine supplementation in exercise, sport, and medicine. J. Int. Soc. Sports Nutr., 14.","DOI":"10.1186\/s12970-017-0173-z"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1017\/S000711451800017X","article-title":"Changing to a vegetarian diet reduces the body creatine pool in omnivorous women, but appears not to affect carnitine and carnosine homeostasis: A randomised trial","volume":"119","author":"Blancquaert","year":"2018","journal-title":"Br. J. Nutr."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"8418","DOI":"10.1016\/S0021-9258(18)52891-X","article-title":"A Na(+)-dependent creatine transporter in rabbit brain, muscle, heart, and kidney. CDNA cloning and functional expression","volume":"268","author":"Guimbal","year":"1993","journal-title":"J. Biol. Chem."},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Fischer, A., Ten Hove, M., Sebag-Montefiore, L., Wagner, H., Clarke, K., Watkins, H., Lygate, C.A., and Neubauer, S. (2010). Changes in creatine transporter function during cardiac maturation in the rat. BMC Dev. Biol., 10.","DOI":"10.1186\/1471-213X-10-70"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/0006-2944(76)90005-3","article-title":"Studies of energy transport in heart cells. intracellular creatine content as a regulatory factor of frog heart energetics and force of contraction","volume":"16","author":"Saks","year":"1976","journal-title":"Biochem. Med."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/0006-2944(78)90017-0","article-title":"Studies of energy transport in heart cells. The effect of creatine phosphate on the frog ventricular contractile force and action potential duration","volume":"19","author":"Rosenshtraukh","year":"1978","journal-title":"Biochem. Med."},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Santacruz, L., Arciniegas, A.J.L., Darrabie, M., Mantilla, J.G., Baron, R.M., Bowles, D.E., Mishra, R., and Jacobs, D.O. (2017). Hypoxia decreases creatine uptake in cardiomyocytes, while creatine supplementation enhances HIF activation. Physiol. Rep., 5.","DOI":"10.14814\/phy2.13382"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1211\/0022357021771805","article-title":"The Effects of creatine on the retrogradely perfused isolated rat heart","volume":"54","author":"Kilian","year":"2002","journal-title":"J. Pharm."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1006\/jmcc.1997.0590","article-title":"Effects of chronic dietary Creatine feeding on cardiac energy metabolism and on creatine content in heart, skeletal muscle, brain, liver and kidney","volume":"30","author":"Horn","year":"1998","journal-title":"J. Mol. Cell Cardiol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1161\/01.CIR.100.18.1847","article-title":"Downregulation of the Na(+)-creatine cotransporter in failing human myocardium and in experimental heart failure","volume":"100","author":"Neubauer","year":"1999","journal-title":"Circulation"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1161\/01.CIR.94.8.1894","article-title":"Creatine kinase system in failing and nonfailing human myocardium","volume":"94","author":"Nascimben","year":"1996","journal-title":"Circulation"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0008-6363(99)00075-9","article-title":"Chronic high-dose creatine feeding does not attenuate left ventricular remodeling in rat hearts post-myocardial infarction","volume":"43","author":"Horn","year":"1999","journal-title":"Cardiovasc. Res."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.1007\/s00726-011-0972-5","article-title":"Creatine but not Betaine supplementation increases muscle Phosphorylcreatine content and strength performance","volume":"42","author":"Roschel","year":"2012","journal-title":"Amino Acids"},{"key":"ref_38","first-page":"1077","article-title":"Creatine supplementation increases soleus muscle creatine content and lowers the insulinogenic index in an animal model of inherited Type 2 Diabetes","volume":"17","author":"Jijakli","year":"2006","journal-title":"Int. J. Mol. Med."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"E399","DOI":"10.1152\/ajpendo.00259.2002","article-title":"Creatine transporter activity and content in the rat heart supplemented by and depleted of creatine","volume":"284","author":"Boehm","year":"2003","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.yjmcc.2009.10.033","article-title":"Mice over-expressing the myocardial creatine transporter develop progressive heart failure and show decreased glycolytic capacity","volume":"48","author":"Phillips","year":"2010","journal-title":"J. Mol. Cell Cardiol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"3131","DOI":"10.1161\/CIRCULATIONAHA.105.572990","article-title":"Supranormal myocardial creatine and phosphocreatine concentrations lead to cardiac hypertrophy and heart failure: Insights from creatine transporter-overexpressing transgenic mice","volume":"112","author":"Wallis","year":"2005","journal-title":"Circulation"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"H373","DOI":"10.1152\/ajpheart.00411.2013","article-title":"Normal cardiac function in mice with supraphysiological cardiac creatine levels","volume":"306","author":"Santacruz","year":"2014","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1007\/s00726-016-2236-x","article-title":"Proteomic and metabolomic changes driven by elevating myocardial creatine suggest novel metabolic feedback mechanisms","volume":"48","author":"Zervou","year":"2016","journal-title":"Amino Acids"},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Mert, K., Ilg\u00fcy, S., Dural, M., Mert, G., and Ozakin, E. (2017). Effects of creatine supplementation on cardiac autonomic functions in bodybuilders. Pacing Clin. Electrophysiol., 40.","DOI":"10.1111\/pace.13096"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1136\/heartjnl-2017-312731","article-title":"Resting heart rate: What is normal?","volume":"104","author":"Nanchen","year":"2018","journal-title":"Heart"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1093\/eurheartj\/ehw128","article-title":"2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The task force for the diagnosis and treatment of acute and chronic heart failure of the european society of cardiology (ESC)developed with the special contribution of the heart failure association (HFA) of the ESC","volume":"37","author":"Ponikowski","year":"2016","journal-title":"Eur. Heart. J."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1161\/01.RES.10.3.333","article-title":"Effects of experimental congestive heart failure, ouabain, and asphyxia on the high-energy phosphate and creatine content of the guinea pig heart","volume":"10","author":"Feinstein","year":"1962","journal-title":"Circ. Res."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1172\/JCI105135","article-title":"High energy phosphate compounds in the myocardium during experimental congestive heart failure. purine and pyrimidine nucleotides, creatine, and creatine phosphate in normal and in failing hearts","volume":"44","author":"Fox","year":"1965","journal-title":"J. Clin. Investig."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1161\/01.CIR.100.20.2113","article-title":"Progressive loss of myocardial ATP due to a loss of total purines during the development of heart failure in dogs: A compensatory role for the parallel loss of creatine","volume":"100","author":"Shen","year":"1999","journal-title":"Circulation"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.yjmcc.2004.11.016","article-title":"Mechanisms of Creatine Depletion in Chronically Failing Rat Heart","volume":"38","author":"Chan","year":"2005","journal-title":"J. Mol. Cell Cardiol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.4067\/S0034-98872010001300001","article-title":"Myocardial Lipids and Creatine Measured by Magnetic Resonance Spectroscopy among Patients with Heart Failure","volume":"138","author":"Winter","year":"2010","journal-title":"Rev. M\u00e9d. Chile"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"2190","DOI":"10.1161\/01.CIR.96.7.2190","article-title":"Myocardial Phosphocreatine-to-ATP Ratio Is a Predictor of Mortality in Patients with Dilated Cardiomyopathy","volume":"96","author":"Neubauer","year":"1997","journal-title":"Circulation"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"19","DOI":"10.2463\/mrms.3.19","article-title":"Assessment of Myocardial Creatine Concentration in Dysfunctional Human Heart by Proton Magnetic Resonance Spectroscopy","volume":"3","author":"Nakae","year":"2004","journal-title":"Magn. Reason. Med. Sci."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1253\/circj.69.711","article-title":"Myocardial Creatine Concentration in Various Nonischemic Heart Diseases Assessed by 1H Magnetic Resonance Spectroscopy","volume":"69","author":"Nakae","year":"2005","journal-title":"Circ. J."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1056\/NEJMra063052","article-title":"The Failing Heart\u2014An engine out of fuel","volume":"356","author":"Neubauer","year":"2007","journal-title":"N. Engl. J. Med."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1161\/01.CIR.0000165147.99592.01","article-title":"Reduced inotropic reserve and increased susceptibility to cardiac ischemia\/reperfusion injury in phosphocreatine-deficient Guanidinoacetate-N-methyltransferase\u2013knockout mice","volume":"111","author":"Lygate","year":"2005","journal-title":"Circulation"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/0022-2828(89)90840-7","article-title":"Adaptation of Cardiac Contractile Function to Conditions of Chronic Energy Deficiency","volume":"21","author":"Kapelko","year":"1989","journal-title":"J. Mol. Cell Cardiol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/S0008-6363(95)00225-1","article-title":"Creatine Supplementation in congestive heart failure","volume":"31","author":"Field","year":"1996","journal-title":"Cardiovasc. Res."},{"key":"ref_59","doi-asserted-by":"crossref","unstructured":"Faller, K.M.E., Medway, D.J., Aksentijevic, D., Sebag-Montefiore, L., Schneider, J.E., Lygate, C.A., and Neubauer, S. (2013). Ribose supplementation alone or with elevated creatine does not preserve high energy nucleotides or cardiac function in the failing mouse heart. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0066461"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1002\/clc.20892","article-title":"Coenzyme Q10 and creatine in heart failure: Micronutrients, macrobenefit?","volume":"34","author":"Ahmed","year":"2011","journal-title":"Clin. Cardiol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1002\/clc.20846","article-title":"Coenzyme Q10 Terclatrate and creatine in chronic heart failure: A randomized, placebo-controlled, double-blind study","volume":"34","author":"Fumagalli","year":"2011","journal-title":"Clin. Cardiol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1590\/S0066-782X2012005000056","article-title":"Influence of creatine supplementation on the functional capacity of patients with heart failure","volume":"99","author":"Carvalho","year":"2012","journal-title":"Arq. Bras. Cardiol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/S0008-6363(95)00062-3","article-title":"Creatine supplementation in chronic heart failure increases skeletal muscle creatine phosphate and muscle performance","volume":"30","author":"Gordon","year":"1995","journal-title":"Cardiovasc. Res."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1053\/euhj.1997.0767","article-title":"The effect of dietary creatine supplementation on skeletal muscle metabolism in congestive heart failure","volume":"19","author":"Andrews","year":"1998","journal-title":"Eur. Heart J."},{"key":"ref_65","first-page":"533","article-title":"Is Creatine supplementation helpful for patients with chronic heart failure?","volume":"19","author":"Schaufelberger","year":"1998","journal-title":"Eur. Heart J."},{"key":"ref_66","first-page":"218","article-title":"Creatine supplementation improves muscle strength in patients with congestive heart failure","volume":"61","author":"Kuethe","year":"2006","journal-title":"Pharmazie"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1002\/med.20255","article-title":"Therapeutic use of creatine in brain or heart ischemia: Available data and future perspectives","volume":"33","author":"Perasso","year":"2013","journal-title":"Med. Res. Rev."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1161\/CIRCRESAHA.112.300725","article-title":"Living without creatine: Unchanged exercise capacity and response to chronic myocardial infarction in creatine-deficient mice","volume":"112","author":"Lygate","year":"2013","journal-title":"Circ. Res."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1113\/jphysiol.2004.067926","article-title":"Phosphorylated guanidinoacetate partly compensates for the lack of phosphocreatine in skeletal muscle of mice lacking guanidinoacetate methyltransferase","volume":"560","author":"Kan","year":"2004","journal-title":"J. Physiol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1161\/hc3901.095933","article-title":"Chronic phosphocreatine depletion by the creatine analogue beta-guanidinopropionate is associated with increased mortality and loss of ATP in rats after myocardial infarction","volume":"104","author":"Horn","year":"2001","journal-title":"Circulation"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1111\/j.1748-1716.2012.02463.x","article-title":"The effect of creatine supplementation on myocardial function, mitochondrial respiration and susceptibility to ischaemia\/reperfusion injury in sedentary and exercised rats","volume":"206","author":"Webster","year":"2012","journal-title":"Acta Physiol."},{"key":"ref_72","doi-asserted-by":"crossref","unstructured":"Horjus, D.L., Oudman, I., van Montfrans, G.A., and Brewster, L.M. (2011). Creatine and creatine analogues in hypertension and cardiovascular disease. Cochrane Database Syst. Rev.","DOI":"10.1002\/14651858.CD005184.pub2"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1007\/s11064-007-9492-9","article-title":"Protective effects of some creatine derivatives in brain tissue anoxia","volume":"33","author":"Perasso","year":"2008","journal-title":"Neurochem. Res."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0005-2728(97)00004-2","article-title":"Uptake of Creatine Phosphate into heart mitochondria: A leak in the creatine shuttle","volume":"1320","author":"Soboll","year":"1997","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_75","first-page":"675","article-title":"Possible mechanism of the protective effect of phosphocreatine on the ischemic myocardium","volume":"51","author":"Dzhavadov","year":"1986","journal-title":"Biokhimiia"},{"key":"ref_76","first-page":"1763","article-title":"Molecular and cellular aspects of the cardioprotective mechanism of phosphocreatine","volume":"57","author":"Saks","year":"1992","journal-title":"Biokhimiia"},{"key":"ref_77","doi-asserted-by":"crossref","unstructured":"Tokarska-Schlattner, M., Epand, R.F., Meiler, F., Zandomeneghi, G., Neumann, D., Widmer, H.R., Meier, B.H., Epand, R.M., Saks, V., and Wallimann, T. (2012). Phosphocreatine interacts with phospholipids, affects membrane properties and exerts membrane-protective Effects. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0043178"},{"key":"ref_78","first-page":"59","article-title":"The effect of exogenous phosphocreatine on maximal walking distance, blood rheology, platelet aggregation, and fibrinolysis in patients with intermittent claudication","volume":"13","author":"Panchenko","year":"1994","journal-title":"Int. Angiol."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S0011-393X(05)80663-0","article-title":"Phosphocreatine: Molecular and cellular aspects of the mechanism of cardioprotective action","volume":"53","author":"Saks","year":"1993","journal-title":"Curr. Ther. Res."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s10557-016-6711-0","article-title":"Anthracycline chemotherapy and cardiotoxicity","volume":"31","author":"McGowan","year":"2017","journal-title":"Cardiovasc. Drugs"},{"key":"ref_81","first-page":"853","article-title":"An Overview of doxorubicin formulations in cancer therapy","volume":"10","author":"Rivankar","year":"2014","journal-title":"J. Cancer Res."},{"key":"ref_82","unstructured":"Saleem, T., and Kasi, A. (2021). Daunorubicin. StatPearls, StatPearls Publishing."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s10565-006-0140-y","article-title":"Adriamycin-induced oxidative mitochondrial cardiotoxicity","volume":"23","author":"Berthiaume","year":"2007","journal-title":"Cell Biol. Toxicol."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"e000665","DOI":"10.1161\/JAHA.113.000665","article-title":"Cancer therapy-induced cardiotoxicity: Basic mechanisms and potential cardioprotective therapies","volume":"3","author":"Hahn","year":"2014","journal-title":"J. Am. Heart Assoc."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0300-483X(99)00039-6","article-title":"Adriamycin-induced changes of creatine kinase activity in vivo and in cardiomyocyte culture","volume":"134","author":"DeAtley","year":"1999","journal-title":"Toxicology"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"H539","DOI":"10.1152\/ajpheart.00108.2012","article-title":"Exposing cardiomyocytes to subclinical concentrations of doxorubicin rapidly reduces their creatine transport","volume":"303","author":"Darrabie","year":"2012","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1124\/mol.61.3.516","article-title":"Multiple interference of anthracyclines with mitochondrial creatine kinases: Preferential damage of the cardiac isoenzyme and its implications for drug cardiotoxicity","volume":"61","author":"Wallimann","year":"2002","journal-title":"Mol. Pharm."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1016\/j.bbabio.2007.08.006","article-title":"Reduced creatine-stimulated respiration in doxorubicin challenged mitochondria: Particular sensitivity of the heart","volume":"1767","author":"Dolder","year":"2007","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1007\/s00726-011-0875-5","article-title":"Creatine as an antioxidant","volume":"40","author":"Sestili","year":"2011","journal-title":"Amino Acids"},{"key":"ref_90","doi-asserted-by":"crossref","unstructured":"Gupta, A., Rohlfsen, C., Leppo, M.K., Chacko, V.P., Wang, Y., Steenbergen, C., and Weiss, R.G. (2013). Creatine kinase-overexpression improves myocardial energetics, contractile dysfunction and survival in murine doxorubicin cardiotoxicity. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0074675"},{"key":"ref_91","doi-asserted-by":"crossref","unstructured":"Aksentijevi\u0107, D., Zervou, S., Faller, K.M.E., McAndrew, D.J., Schneider, J.E., Neubauer, S., and Lygate, C.A. (2014). Myocardial creatine levels do not influence response to acute oxidative stress in isolated perfused heart. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0109021"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1111\/j.1440-1681.2007.04717.x","article-title":"Chronic supplementation of creatine and vitamins C and E increases survival and improves biochemical parameters after doxorubicin treatment in rats","volume":"34","author":"Santos","year":"2007","journal-title":"Clin. Exp. Pharm. Physiol."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1080\/07315724.2003.10719272","article-title":"Vitamin C as an antioxidant: Evaluation of its role in disease prevention","volume":"22","author":"Padayatty","year":"2003","journal-title":"J. Am. Coll. Nutr."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0083-6729(07)76001-6","article-title":"Vitamin E","volume":"76","author":"Mustacich","year":"2007","journal-title":"Vitam. Horm."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1007\/s12012-014-9283-x","article-title":"Creatine supplementation reduces doxorubicin-induced cardiomyocellular injury","volume":"15","author":"Santacruz","year":"2015","journal-title":"Cardiovasc. Toxicol."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1080\/01635581.2017.1295089","article-title":"Creatine supplementation and doxorubicin-induced skeletal muscle dysfunction: An ex vivo investigation","volume":"69","author":"Bredahl","year":"2017","journal-title":"Nutr. Cancer"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1080\/01635581.2019.1623900","article-title":"Effects of creatine supplementation on muscle fatigue in rats receiving doxorubicin treatment","volume":"72","author":"Torok","year":"2020","journal-title":"Nutr. Cancer"},{"key":"ref_98","first-page":"514","article-title":"Effect of creatine phosphate sodium on miRNA378, miRNA378* and calumenin mRNA in adriamycin-injured cardiomyocytes","volume":"32","author":"Miao","year":"2016","journal-title":"Zhongguo Ying Yong Sheng Li Xue Za Zhi"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1007\/s00795-017-0176-5","article-title":"Creatine phosphate disodium salt protects against dox-induced cardiotoxicity by increasing calumenin","volume":"51","author":"Wang","year":"2018","journal-title":"Med. Mol. Morphol."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"82","DOI":"10.3909\/ricm0867","article-title":"Role of exogenous phosphocreatine in chemotherapy-induced cardiomyopathy","volume":"18","author":"Parve","year":"2017","journal-title":"Rev. Cardiovasc. Med."},{"key":"ref_101","doi-asserted-by":"crossref","unstructured":"Cheuk, D.K.L., Sieswerda, E., van Dalen, E.C., Postma, A., and Kremer, L.C.M. (2016). medical interventions for treating anthracycline-induced symptomatic and asymptomatic cardiotoxicity during and after treatment for childhood cancer. Cochrane Database Syst. Rev., CD008011.","DOI":"10.1002\/14651858.CD008011.pub3"}],"container-title":["Nutrients"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6643\/13\/4\/1215\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T13:58:46Z","timestamp":1760363926000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6643\/13\/4\/1215"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,7]]},"references-count":101,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2021,4]]}},"alternative-id":["nu13041215"],"URL":"https:\/\/doi.org\/10.3390\/nu13041215","relation":{},"ISSN":["2072-6643"],"issn-type":[{"value":"2072-6643","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,7]]}}}